Rokhman, M. Rifqi http://orcid.org/0000-0002-0608-3084
Wardhani, Yulia
Partiningrum, Dwi Lestari
Purwanto, Barkah Djaka
Hidayati, Ika Ratna
Idha, Arofa
Thobari, Jarir At
Postma, Maarten J.
Boersma, Cornelis
van der Schans, Jurjen
Funding for this research was provided by:
LPDP (PRJ-1/LPDP.3/2019)
Article History
Accepted: 8 August 2022
First Online: 29 August 2022
Declarations
:
: MJP reports grants and honoraria from various pharmaceutical companies, including those developing, producing and marketing diabetes drugs. However, all grants and honoraria were fully unrelated to this specific study. The other authors declare that they have no competing interests related to this specific study and topic.
: The study was approved by the Medical and Health Research Ethics Committee (MHREC), Faculty of Medicine, Public Health and Nursing, Gadjah Mada–Dr. Sardjito General Hospital with document number KE/FK/0953/EC/2020 on 27 August 2020.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.